Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01442701 · ClinicalTrials.gov registry record
Stanford's Outcomes Research in Kids
A clinical trial of Bacterial, Viral and Other Infectious Agents, sponsored by Stanford University.
- Completed
- Registry status
- 361
- Enrollment target
- 1
- Study location
NCT01442701: Completed study of Bacterial, Viral and Other Infectious Agents, sponsored by Stanford University.
NCT01442701 is a study of Bacterial, Viral and Other Infectious Agents that has completed, run by Stanford University. The registered enrollment target is 361 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01442701, a study of Bacterial, Viral and Other Infectious Agents, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 361 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators intend to investigate whether the rise in childhood obesity is caused by the loss of recurrent and chronic infections in modern, industrialized society, beginning in utero and extending through early childhood. The investigators will also examine whether the antimicrobial triclosan, present in numerous cleaning and hygiene products, decreases the incidence of infection within a household.
Primary Outcome
We will determine whether an association exists between height-for-weight Z-score (with adjustment for age and sex) and infectious disease load.
Conditions Studied
Interventions
- OTHER Removal of triclosan-containing cleaning products from household.
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 361 participants |
| Start Date | 2011-11-17 |
| Est. Completion | 2019-12-01 |
What the finished NCT01442701 record still lists
NCT01442701 is an observational study that tracks outcomes without assigning an intervention. The registered 361 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Bacterial, Viral and Other Infectious Agents appearing as the primary indexed condition, and to 1 intervention - of which Removal of triclosan-containing cleaning products from household. is the first listed.
NCT01442701 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01442701 about?
NCT01442701 is a clinical study titled "Stanford's Outcomes Research in Kids". The investigators intend to investigate whether the rise in childhood obesity is caused by the loss of recurrent and chronic infections in modern, industrialized society, beginning in utero and extending through early childhood. The investigators will also examine whether the antimicrobial triclosan...
What is the current status of trial NCT01442701?
This trial is currently completed. The enrollment target is 361 participants. The study started on 2011-11-17. Estimated completion is 2019-12-01.
What conditions does trial NCT01442701 study?
This clinical trial studies the following conditions: Bacterial, Viral and Other Infectious Agents.
What interventions are being tested in trial NCT01442701?
The interventions under investigation include: Removal of triclosan-containing cleaning products from household. (OTHER).
Who is sponsoring clinical trial NCT01442701?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01442701 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05533697 · 361 participants · Phase 1
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- NCT04988555 · 362 participants · Phase 1
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
- NCT05536141 · 362 participants · Phase 1
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- NCT06534983 · 362 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI